[专注于精神药物相互作用 - 开发一个11项工具来比较精神病学实践的相互作用数据库]
Liv Ilgner1, Andreas Eckert2, Sibylle C Roll1,3
1Klinik für psychische Gesundheit, varisano Klinikum Frankfurt Höchst.
Psychiatrische Praxis
|November 12, 2025
概括
对药物相互作用数据库进行比较对于精神病治疗至关重要. 一个新的评估系统显示,在检测互动方面,付费数据库明显优于免费数据库.
科学领域:
- 药理学 药理学是指药理学的学科.
- 医疗信息学 医疗信息学
- 精神病学是一个精神病学.
背景情况:
- 精神病药物具有很高的药物相互作用潜力.
- 准确识别这些相互作用对于患者的安全至关重要.
- 现有的药物相互作用数据库在全面性和准确性方面各不相同.
研究的目的:
- 开发和试点测试一种用于比较药物相互作用数据库的新型评估系统.
- 在精神病学背景下系统评估多种药物相互作用数据库的性能.
主要方法:
- 分析了一组104名精神病患者的药物计划.
- 在12个不同的相互作用数据库中检查了药物相互作用.
- 一个新开发的评价系统,包含11个标准和一个评分机制,用于评估.
主要成果:
- 在数据库中观察到的相互作用数量的显著变化.
- 没有一个单一的数据库确定了所有潜在的相互作用.
- 付费数据库 (平均得分6.4±2.5) 的表现明显优于免费数据库 (1.5±2.4,p=0.009).
- 最好的结果来自ifap和PGXperts数据库.
结论:
- 药物相互作用数据库在性能上有很大差异.
- 建议利用多个数据库,临床专业知识和跨学科合作来管理心理药物相互作用.
更多相关视频
相关概念视频
Pharmacokinetics: Drug–Drug Interactions
332
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
332
Drug Dosing: Geriatric Patients
215
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
215
Dosage Regimens: Partial Pharmacokinetic Parameters
141
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
141
Antidepressant Drugs: Overview
1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
Dosage Regimen: Individualization
160
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
160
Dosage Regimens: Designs and Approaches
248
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
248


